Perfusion imaging of high-grade gliomas: a comparison between contrast harmonic and magnetic resonance imaging. Technical note.

Transcranial contrast harmonic (CH) imaging is emerging as a promising tool for the evaluation of brain perfusion. The authors report on two cases of histologically proven high-grade gliomas evaluated using CH imaging in comparison to perfusion magnetic resonance (pMR) imaging. In both cases, pMR imaging results demonstrated a massive decrease in signal intensity and an elevated regional cerebral blood volume (rCBV) in the tumor region; however, signal decrease was less prominent and rCBV was lower in healthy brain tissue. In one patient, the rCBV ratio of tumor/brain was 5.0 and the maximal signal decay occurred 3.1 times deeper in the tumor than in the healthy brain tissue. Results of an ultrasonography examination using CH imaging revealed similar data: the tumor/brain ratio for the area under the curve, a parameter corresponding to rCBV, was 4.1. The maximal signal intensity in the tumor was 3.3 times greater than in adjacent healthy brain. Comparable data were obtained in a second patient. Taken together, these findings indicate that CH imaging may be a valuable alternative to pMR imaging. This new, cost-effective bedside ultrasonic technique could be helpful not only as a means of noninvasive staging of gliomas but also as a follow-up imaging modality to evaluate postoperative tumor recurrence or response to antiangiogenic therapy.

[1]  H. Aronen,et al.  Dynamic susceptibility contrast MRI of gliomas. , 2002, Neuroimaging clinics of North America.

[2]  H. Przuntek,et al.  Contrast Burst Depletion Imaging (CODIM): A New Imaging Procedure and Analysis Method for Semiquantitative Ultrasonic Perfusion Imaging , 2003, Stroke.

[3]  D O Cosgrove,et al.  Microbubble contrast agents: a new era in ultrasound , 2001, BMJ : British Medical Journal.

[4]  G. Taylor,et al.  Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent. , 1996, Radiology.

[5]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[6]  C. Harvey,et al.  Ultrasound of focal liver lesions , 2001, European Radiology.

[7]  P. Burns Harmonic imaging with ultrasound contrast agents. , 1996, Clinical radiology.

[8]  J. Harrer,et al.  Second harmonic imaging: a new ultrasound technique to assess human brain tumour perfusion , 2003, Journal of neurology, neurosurgery, and psychiatry.

[9]  A. Krone,et al.  Reliability of transcranial colour-coded real-time sonography in assessment of brain tumours: correlation of ultrasound, computed tomography and biopsy findings , 1994, Neuroradiology.

[10]  U. Knopp,et al.  Transcranial Sonography of Brain Tumors in the Adult: An In Vitro and In Vivo Study , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[11]  G. Becker,et al.  Postoperative neuroimaging of high-grade gliomas: comparison of transcranial sonography, magnetic resonance imaging, and computed tomography. , 1999, Neurosurgery.

[12]  G. Seidel,et al.  Harmonic imaging--a new method for the sonographic assessment of cerebral perfusion. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[13]  Helmut Ermert,et al.  Comparison Between Echo Contrast Agent-Specific Imaging Modes and Perfusion-Weighted Magnetic Resonance Imaging for the Assessment of Brain Perfusion , 2002, Stroke.

[14]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[15]  V L Newhouse,et al.  Second harmonic ultrasonic blood perfusion measurement. , 1993, Ultrasound in medicine & biology.

[16]  H. Przuntek,et al.  Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.